Geneia CEO discusses role of population health and SDoH in health system recovery
June 22, 2020
Harrisburg, PA – Geneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, announces its president and CEO, Heather Lavoie, will discuss the role of social determinants of health (SDoH) and population health in health system recovery at the Virtual Summit on Health System Recovery from the COVID-19 Pandemic.
“With more than 60 percent of people say they have been adversely impacted by social determinants during the pandemic and they will wait one to six months to seek routine care, we know health system efforts to restart regular healthcare will be quite challenging,” said Lavoie. “Geneia’s work with hospitals and physicians suggests a digital front door strategy that lets patients know they are truly known and cared for is essential.”
Lavoie’s panel, The Role of Population Health and Social Determinants of Health in Health System Recovery, will be June 25 at 2:05 pm Eastern. Hosted by David B. Nash, MD, MBA, founding dean emeritus and Dr. Raymond C. & Doris N. Grandon professor of health policy, Jefferson College of Population Health, panelists will include:
- Dave A. Chokski, MD, MSc, FACP, vice president and chief population health officer, NYC Health + Hospitals, CEO, NYC Health + Hospitals Accountable Care Organization
- Luis LaSalvia, MD, MBA, vice president and global medical officer, Siemens
The Virtual Summit on Health System Recovery from the COVID-19 Pandemic runs June 22-25, 2020. For more information, visit: healthsystemcovidrecovery.com.
To read Lavoie’s blog, Restarting regular care: Nine ways to get patients back to the office, click here.
Geneia LLC is a healthcare analytics and services company. We work to improve collaboration between healthcare providers, health plans and employers to better support personalized, patient-centered care. Through advanced technology, education and training, insights and clinical services, we help clients better identify and actively manage high-risk populations, improve quality measurement and outcomes, and strengthen revenue. Rooted in deep clinical experience and leading-edge data science, our client-centric, phased approach to population health simplifies the transition to risk and value-based care. Our offices are located in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com (https://www.geneia.com) or connect with us on Facebook, Twitter and LinkedIn.